In the subgroup analysis, CD patients had significantly lower baseline serum albumin levels compared to the UC group (CD: 3.84 ± 0.65 g/dL vs. UC: 4.12 ± 0.66 g/dL, p = 0.027); this may be due to the severity of the IBD. The gene discussed is ALB; the disease is inflammatory bowel disease.